Latest AI and machine learning research in other cancers for healthcare professionals.
UNLABELLED: Hepatocellular carcinoma (HCC) remains a major global health burden with persistently hi...
Despite advancements in therapeutic cancer vaccines, clinical translation has been hindered by limit...
INTRODUCTION: Biliary tract cancer (BTC) is a biologically heterogeneous and highly aggressive malig...
BACKGROUND: Lipid droplet (LD)-associated metabolic reprogramming plays a critical role in breast ca...
PURPOSE: Gastric-type endocervical adenocarcinoma (GAS) is an aggressive, non-HPV-associated cervica...
PURPOSE: POSEIDON (NCT03164616) was a randomized, open-label, multicenter phase 3 trial comparing fi...
MOTIVATION: Accurate survival prediction is crucial for personalized cancer treatment but remains ch...
BACKGROUND: PCLAF (PCNA clamp-associated factor) is a protein involved in DNA replication and DNA re...
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with a poor prognosis. T...
BACKGROUND: Childhood T-lineage acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic ma...
Keratins (KRTs) are intermediate filament proteins expressed in epithelial cells and serve as diagno...
Assessing venous thromboembolism (VTE) risk after immunotherapy remains important for lung cancer ma...
Lung cancer (LC) is a malignant tumor that poses a serious threat to human health. Positron emission...
BACKGROUND: Treatment-free remission (TFR) has become a treatment goal for chronic myeloid leukemia ...
Immunotherapy has revolutionized the treatment landscape of breast cancer, particularly for triple-n...
Inflammatory orbital diseases are characterized by inflammation that may involve any structure of th...
Breast cancer classification has undergone significant evolution; however, the long-standing binary ...
This study aims to automatically detect, classify, and stage bone apposition changes in the mandibul...
BACKGROUND: Muscle-invasive bladder cancer (MIBC) is an aggressive and heterogeneous malignancy with...
BACKGROUND: Neoadjuvant therapy (NAT) is crucial for locally advanced breast cancer, but post-NAT ly...
Neoadjuvant therapy (NAT) has strengthened systemic control in breast cancer and promoted precision ...